Atovaquone Oral Suspension
NDC 10702-223, Atovaquone, suspension, from KVK-Tech, Inc..
- Product NDC
- 10702-223
- Status
- Listed
- Labeler
- KVK-Tech, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210510
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10702-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOVAQUONE750 mg/5mL
Pharmacologic classes
Antimalarial [EPC]; Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10702-223-21 | 10702022321 | 1 BOTTLE, PLASTIC in 1 CARTON (10702-223-21) / 210 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b31ff20a-c363-4be0-9bc0-3081c163b63cNADAC price for package 10702022321
GET /v1/drugs/nadac/10702022321
Use it
Look up 10702-223 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10702-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10702-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.